ASCO 2022 Conference Review: Exciting New Developments and Trends
By Andrew Zupnick, PhD, VP, Oncology Drug Development at Catalyst Clinical Research Catalyst Oncology strives to stay at the forefront of new developments in the industry; when it comes to cancer care, we believe that every second counts. That is why we were delighted...
Catalyst in the Community for National Volunteer Week
At Catalyst, our company culture is rooted in our people-first foundational belief and a desire to do the right thing. From our philanthropy and volunteering to our sustainability initiatives, we strive to collaborate openly and inclusively for the best impact on...
COSMIC-19 Abstract Published in the British Journal of Anaesthesia
An abstract that focuses on COSMIC 19, a project funded by the iMATCH consortium, has been published in the British Journal of Anaesthesia (BJA). The abstract evaluated how the use of ‘continuous vital signs’ monitors could offer non-stop observations of ward-based...
Trial of Wearable Health Technology for Cancer Patients Opens
A new trial opens in Greater Manchester today which is to test cutting-edge wearable technologies involving patients who have received cancer treatment. The commercially-available health sensors and devices produce a digital fingerprint of vital signs that could allow...
